Crystal structures,thermal stabilities,and dissolution behaviours of tinidazole and the tinidazole–vanillic acid cocrystal: insights from energy frameworks

The crystal structures of the antimicrobial drug tinidazole [ TNZ ; systematic name: 1‐(2‐ethylsulfonylethyl)‐2‐methyl‐5‐nitroimidazole, C₈H₁₃N₃O₄S] and the 1:1 cocrystal of TNZ with the naturally occurring compound vanillic acid ( VA ; systematic name: 4‐hydroxy‐3‐methoxybenzoic acid, C₈H₈O₄), namely, the TNZ – VA cocrystal, were determined by single‐crystal X‐ray analysis at 100 K. The supramolecular structure of the TNZ – VA cocrystal is composed of a carboxylic acid dimer and an O—H…N(heterocycle) synthon in the form of layers made up of O—H…N and O—H…O hydrogen bonds. The layers are joined via C—H…O hydrogen bonds, π–π stacking and C—H…π interactions. The energy framework analysis, together with interaction energy calculations using the DLPNO‐CCSD(T) method, indicates that the TNZ – VA cocrystal inherits strong interactions from the TNZ and VA crystals, which accounts for the enhanced thermal stability and reduced dissolution rate. To the best of our knowledge, this is the first example of a cocrystal containing TNZ .     

Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry

Genotoxic impurity control has been a great concern in the pharmaceutical industry since the recall of the large round of sartans worldwide in 2018. In these sartans, N-nitrosamines were the main contaminants in active pharmaceutical ingredients and formulations. Numerous analytical methods have been developed to detect N-nitrosamines in food, drugs, and environmental samples. In this study, a sensitive method is developed for the trace determination of N-nitrosamine impurities in metronidazole benzoate pharmaceuticals using high-performance liquid chromatography/atmospheric-pressure chemical ionization tandem mass spectrometry in the multiple reaction monitoring mode. The method was validated regarding system suitability, selectivity, linearity, accuracy, precision, sensitivity, solution stability, and robustness. The method showed good linearity with R² ≥ 0.999 and F_Mandel < F_tab(95%) ranging from 0.33 to 8.00 ng/ml. The low limits of detection of N-nitrosamines were in the range of 0.22–0.80 ng/ml (0.0014–0.0050 ppm). The low limits of quantification were in the range of 0.33–1.20 ng/ml (0.0021–0.0075 ppm), which were lower than the acceptable limits in metronidazole benzoate pharmaceuticals and indicated the high sensitivity of the method. The recoveries of N-nitrosamines ranged from 84% to 97%. Thus, this method exhibits good selectivity, sensitivity, and accuracy. Moreover, it is a simple, convenient, and scientific strategy for detecting N-nitrosamine impurities in pharmaceuticals to support the development of the pharmaceutical industry.     

Mixed Ca/Sr salt forms of salicylic acid: tuning structure and aqueous solubility

Ten isostructural single‐crystal diffraction studies of mixed cation Ca/Sr salt forms of the salicylate anion are presented, namely catena‐poly[[diaquacalcium(II)/strontium(II)]‐bis(μ₂‐2‐hydroxybenzoato)], [Ca_1–xSr_x(C₇H₅O₃)₂(H₂O)₂]_n, where x = 0, 0.041, 0.083, 0.165, 0.306, 0.529, 0.632, 0.789, 0.835 and 1. The structure of an isostructural Sr/Ba species, namely catena‐poly[[diaquastrontium(II)/barium(II)]‐bis(μ₂‐2‐hydroxybenzoato)], [Sr_0.729Ba_0.271(C₇H₅O₃)₂(H₂O)₂], is also described. The Ca/Sr structures form a series where, with increasing Sr content, the unit cell expands in both the crystallographic a and c directions (by 1.80 and 3.18%, respectively), but contracts slightly in the b direction (−0.31%). The largest percentage structural expansion lies parallel to the direction of propagation of the one‐dimensional coordination polymer that is the primary structural feature. This structural expansion is thus associated with increased M—O distances. Aqueous solubility measurements show that solubility generally increases with increasing Sr content. Thus, tuning the composition of these mixed counter‐ion salt forms leads to systematic structural changes and allows solubility to be tuned to values between those for the pure Ca and Sr species.     

Binary polymorphic cocrystals: an update on the available literature in the Cambridge Structural Database,including a new polymorph of the pharmaceutical 1:1 cocrystal theophylline–3,4‐dihydroxybenzoic acid

An analysis and classification of the 2925 neutral binary organic cocrystals in the Cambridge Structural Database is reported, focusing specifically on those both showing polymorphism and containing an active pharmaceutical ingredient (API). The search was confined to molecules having only C, H, N, O, S and halogens atoms. It was found that 400 out of 2925 cocrystals can be classified as pharmaceutical cocrystals, containing at least one API, and that of those, 56 can be classified as being polymorphic cocrystals. In general, the total number of polymorphic cocrystal systems of any type stands at 125. In addition, a new polymorph of the pharmaceutical cocrystal theophylline–3,4‐dihydroxybenzoic acid (1/1), C₇H₈N₄O₂·C₇H₆O₄, is reported.     

Covalent‐assisted supramolecular synthesis: the effect of hydrogen bonding in cocrystals of 4‐tert‐butylbenzoic acid with isoniazid and its derivatized forms

A series of cocrystals of isoniazid and four of its derivatives have been produced with the cocrystal former 4‐tert‐butylbenzoic acid via a one‐pot covalent and supramolecular synthesis, namely 4‐tert‐butylbenzoic acid–isoniazid, C₆H₇N₃O·C₁₁H₁₄O₂, 4‐tert‐butylbenzoic acid–N′‐(propan‐2‐ylidene)isonicotinohydrazide, C₉H₁₁N₃O·C₁₁H₁₄O₂, 4‐tert‐butylbenzoic acid–N′‐(butan‐2‐ylidene)isonicotinohydrazide, C₁₀H₁₃N₃O·C₁₁H₁₄O₂, 4‐tert‐butylbenzoic acid–N′‐(diphenylmethylidene)isonicotinohydrazide, C₁₉H₁₅N₃O·C₁₁H₁₄O₂, and 4‐tert‐butylbenzoic acid–N′‐(4‐hydroxy‐4‐methylpentan‐2‐ylidene)isonicotinohydrazide, C₁₂H₁₇N₃O₂·C₁₁H₁₄O₂. The co‐former falls under the classification of a `generally regarded as safe' compound. The four derivatizing ketones used are propan‐2‐one, butan‐2‐one, benzophenone and 3‐hydroxy‐3‐methylbutan‐2‐one. Hydrogen bonds involving the carboxylic acid occur consistently with the pyridine ring N atom of the isoniazid and all of its derivatives. The remaining hydrogen‐bonding sites on the isoniazid backbone vary based on the steric influences of the derivative group. These are contrasted in each of the molecular systems.     

Crystal structures of the pyrazinamide–p‐aminobenzoic acid (1/1) cocrystal and the transamidation reaction product 4‐(pyrazine‐2‐carboxamido)benzoic acid in the molten state

The synthesis of pharmaceutical cocrystals is a strategy to enhance the performance of active pharmaceutical ingredients (APIs) without affecting their therapeutic efficiency. The 1:1 pharmaceutical cocrystal of the antituberculosis drug pyrazinamide (PZA) and the cocrystal former p‐aminobenzoic acid (p‐ABA), C₇H₇NO₂·C₅H₅N₃O, (1), was synthesized successfully and characterized by relevant solid‐state characterization methods. The cocrystal crystallizes in the monoclinic space group P2₁/n containing one molecule of each component. Both molecules associate via intermolecular O—H...O and N—H...O hydrogen bonds [O...O = 2.6102 (15) Å and O—H...O = 168.3 (19)°; N...O = 2.9259 (18) Å and N—H...O = 167.7 (16)°] to generate a dimeric acid–amide synthon. Neighbouring dimers are linked centrosymmetrically through N—H...O interactions [N...O = 3.1201 (18) Å and N—H...O = 136.9 (14)°] to form a tetrameric assembly supplemented by C—H...N interactions [C...N = 3.5277 (19) Å and C—H...N = 147°]. Linking of these tetrameric assemblies through N—H...O [N...O = 3.3026 (19) Å and N—H...O = 143.1 (17)°], N—H...N [N...N = 3.221 (2) Å and N—H...N = 177.9 (17)°] and C—H...O [C...O = 3.5354 (18) Å and C—H...O = 152°] interactions creates the two‐dimensional packing. Recrystallization of the cocrystals from the molten state revealed the formation of 4‐(pyrazine‐2‐carboxamido)benzoic acid, C₁₂H₉N₃O₃, (2), through a transamidation reaction between PZA and p‐ABA. Carboxamide (2) crystallizes in the triclinic space group P with one molecule in the asymmetric unit. Molecules of (2) form a centrosymmetric dimeric homosynthon through an acid–acid O—H...O hydrogen bond [O...O = 2.666 (3) Å and O—H...O = 178 (4)°]. Neighbouring assemblies are connected centrosymmetrically via a C—H...N interaction [C...N = 3.365 (3) Å and C—H...N = 142°] engaging the pyrazine groups to generate a linear chain. Adjacent chains are connected loosely via C—H...O interactions [C...O = 3.212 (3) Å and C—H...O = 149°] to generate a two‐dimensional sheet structure. Closely associated two‐dimensional sheets in both compounds are stacked via aromatic π‐stacking interactions engaging the pyrazine and benzene rings to create a three‐dimensional multi‐stack structure.     

Crystal and Molecular Structure of 4-Hydroxy-3-Methoxy-4-N-Methylstilbazonium Iodide C15H16NO2+·I-

The crystal structure of the title compound C15H16NO2+ · I-(Mr=369. 19) has been determined by single crystal X-ray diffraction analysis. The crystal belongs to tbe monoclinic system with space group P21/c, a=8. 957(1), b=21. 8117(2), c=7. 8760(10)A , β=103.94(1)°, V=1493.8(3)A3, Z=4, Dc=1. 642g cm3,μ=2. 141mm-1, F(000)=728, final R=0. 0264, and Rw=0. 0644(I＞2σ(I)) for 2938 independent reflections. The results show that in the crystal structure of the title compound the planar cations have two configurations, and these cations are anti-parallelly packed through the strong π…π interaction.     

New 1:1 and 2:1 salts in the `dl‐norvaline–maleic acid' system as an example of assembling various crystal structures from similar supramolecular building blocks

Molecular salts and cocrystals of amino acids have potential applications as molecular materials with nonlinear optical, ferroelectric, piezoelectric, and other various target physical properties. The wide choice of amino acids and coformers makes it possible to design various crystal structures. The amino acid–maleic acid system provides a perfect example of a rich variety of crystal structures with different stoichiometries, symmetries and packing motifs built from the molecular building blocks, which are either exactly the same, or differ merely by protonation or as optical isomers. The present paper reports the crystal structures of two new salts of the dl ‐norvaline–maleic acid system with 1:1 and 2:1 stoichiometries, namely dl ‐norvalinium hydrogen maleate, C₅H₁₂NO₂⁺·C₄H₃O₄⁻, (I), and dl ‐norvalinium hydrogen maleate–dl ‐norvaline, C₅H₁₂NO₂⁺·C₄H₃O₄⁻·C₅H₁₁NO₂, (II). These are the first examples of molecular salts of dl ‐norvaline with an organic anion. The crystal structure of (I) has the same C ₂²(12) structure‐forming motif which is common for hydrogen maleates of amino acids. The structure of (II) has dimeric cations. Of special interest is that the single crystals of (I) which are originally formed on crystallization from aqueous solution transform into single crystals of (II) if stored in the mother liquor for several hours.     

The challenging case of the theophylline–benzamide cocrystal

Theophylline has been used as an active pharmaceutical ingredient (API) in the treatment of pulmonary diseases, but due to its low water solubility reveals very poor bioavailability. Based on its different hydrogen‐bond donor and acceptor groups, theophylline is an ideal candidate for the formation of cocrystals. The crystal structure of the 1:1 benzamide cocrystal of theophylline, C₇H₈N₄O₂·C₇H₇NO, was determined from synchrotron X‐ray powder diffraction data. The compound crystallizes in the tetragonal space group P4₁ with four independent molecules in the asymmetric unit. The molecules form a hunter's fence packing. The crystal structure was confirmed by dispersion‐corrected DFT calculations. The possibility of salt formation was excluded by the results of Raman and ¹H solid‐state NMR spectroscopic analyses.     

A novel crystal form of metacetamol: the first example of a hydrated form

We report the crystal structure and crystallization conditions of a first hydrated form of metacetamol (a hemihydrate), C₈H₉NO₂·0.5H₂O. It crystallizes from metacetamol‐saturated 1:1 (v/v) water–ethanol solutions in a monoclinic structure (space group P2₁/n) and contains eight metacetamol and four water molecules per unit cell. The conformations of the molecules are the same as in polymorph II of metacetamol, which ensures the formation of hydrogen‐bonded dimers and R₂²(16) ring motifs in its crystal structure similar to those in polymorph II. Unlike in form II, however, these dimers in the hemihydrate are connected through water molecules into infinite hydrogen‐bonded molecular chains. Different chains are linked to each other by metacetamol–water and metacetamol–metacetamol hydrogen bonds, the latter type being also present in polymorph I. The overall noncovalent network of the hemihydrate is well developed and several types of hydrogen bonds are responsible for its formation.     

一维链状配位聚合物[Co(imbz)_2(H_2O)_2]_n[imbz=4′-(1-咪唑基亚甲基)苯甲酸根]的合成及晶体结构(英文)

０ＩｎｔｒｏｄｕｃｔｉｏｎＮｕｍｅｒｏｕｓｕｎｉｑｕｅｆｒａｍｅｗｏｒｋｓｈａｖｅｂｅｅｎｒｅｐｏｒｔｅｄｂｙａｓｓｅｍｂｌｙｏｆｒａｔｉｏｎａｌｄｅｓｉｇｎｅｄｏｒｇａｎｉｃｌｉｇ-ａｎｄｓｗｉｔｈｍｅｔａｌｉｏｎｓｏｖｅｒｔｈｅｐａｓｔｄｅｃａｄｅ１～３．Ｉｔｉｓｋｎｏｗｎｔｈａｔｂｏｔｈｉｍｉｄａｚｏｌｅａｎｄｃａｒｂｏｘｙｌａｔｅａｒｅｆｕｎｃｔｉｏｎａｌｇｒｏｕｐｓｆｏｒｃｏｏｒｄｉｎａｔｉｏｎｔｏｔｒａｎｓｉｔｉｏｎｍｅｔａｌｉｏｎｓｔｏｆｏｒｍｃｏｍｐｌｅｘｅｓ４～６．Ｈｏｗｅｖｅ…     

Halogen versus Hydrogen Bonding in Binary Cocrystals: Novel Conformation a Coformer with [2+2] Photoreactivity of Criss-Crossed C=C Bonds

A series of cocrystals involving the hydrogen- and halogen-bond donor coformers catechol ( cat ) and 1,2-diiodotetrafluorobenzene ( 1,2-di-I-tFb ), respectively, is reported. Each coformer forms a cocrystal with each of the three symmetric bipyridines trans-1,2-bis(n-pyridyl)ethylene ( n , n′ -bpe , where: n=n′=2, 3, 4). Four novel cocrystals ( cat ) ⋅ ( 3,3′-bpe ), 2( 1,2-di-I-tFb ) ⋅ ( 2,2′-bpe ), 2( 1,2-di-I-tFb ) ⋅ ( 3,3′-bpe ), and ( 1,2-di-I-tFb ) ⋅ ( 4,4′-bpe ) comprise components that assemble by either O−H⋅⋅⋅N hydrogen bonds ( cat ) or N⋅⋅⋅I halogen bonds ( 1,2-di-I-tFb ). In ( cat ) ⋅ ( 3,3′-bpe ), cat acts as a template to support an intermolecular [2+2] photocycloaddition of 3,3′-bpe . The reactivity occurs via a one-dimensional (1D) hydrogen-bonded tape with stacked and criss-crossed olefins that react stereoselectively and quantitatively to form rctt-tetrakis(3-pyridyl)cyclobutane ( 3,3′-tpcb ). The reactivity of the criss-crossed olefins is facilitated by a hitherto not reported cis-gauche conformation adopted by cat . The stereochemistry of 3,3′-tpcb is confirmed in the cocrystal 2( cat ) ⋅ ( 3,3′-tpcb ).     

Cocrystals of the antibiotic trimethoprim with glutarimide and 3,3‐dimethylglutarimide held together by three hydrogen bonds

The antibiotic trimethoprim [5‐(3,4,5‐trimethoxybenzyl)pyrimidine‐2,4‐diamine] was cocrystallized with glutarimide (piperidine‐2,6‐dione) and its 3,3‐dimethyl derivative (4,4‐dimethylpiperidine‐2,6‐dione). The cocrystals, viz. trimethoprim–glutarimide (1/1), C₁₄H₁₈N₄O₃·C₅H₇NO₂, (I), and trimethoprim–3,3‐dimethylglutarimide (1/1), C₁₄H₁₈N₄O₃·C₇H₁₁NO₂, (II), are held together by three neighbouring hydrogen bonds (one central N—H...N and two N—H...O) between the pyrimidine ring of trimethoprim and the imide group of glutarimide, with an ADA/DAD pattern (A = acceptor and D = donor). These heterodimers resemble two known cocrystals of trimethoprim with barbituric acid and its 5,5‐diethyl derivative. Trimethoprim shows a conformation in which the planes of the pyrimidine and benzene rings are approximately perpendicular to one another. In its glutarimide coformer, five of the six ring atoms lie in a common plane; the C atom opposite the N atom deviates by about 0.6 Å. The crystal packing of each of the two cocrystals is characterized by an extended network of hydrogen bonds and contains centrosymmetrically related trimethoprim homodimers formed by a pair of N—H...N hydrogen bonds. This structural motif occurs in five of the nine published crystal structures in which neutral trimethoprim is present.     

The crystal and molecular structures of three copper‐containing complexes and their activities in mimicking galactose oxidase

The structures of three copper‐containing complexes, namely (benzoato‐κ²O,O′)[(E)‐2‐({[2‐(diethylamino)ethyl]imino}methyl)phenolato‐κ³N,N′,O]copper(II) dihydrate, [Cu(C₇H₅O₂)(C₁₃H₁₉N₂O)]·2H₂O, 1 , [(E)‐2‐({[2‐(diethylamino)ethyl]imino}methyl)phenolato‐κ³N,N′,O](2‐phenylacetato‐κ²O,O′)copper(II), [Cu(C₈H₇O₂)(C₁₃H₁₉N₂O)], 2 , and bis[μ‐(E)‐2‐({[3‐(diethylamino)propyl]imino}methyl)phenolato]‐κ⁴N,N′,O:O;κ⁴O:N,N′,O‐(μ‐2‐methylbenzoato‐κ²O:O′)copper(II) perchlorate, [Cu₂(C₈H₇O₂)(C₁₂H₁₇N₂O)₂]ClO₄, 3 , have been reported and all have been tested for their activity in the oxidation of d ‐galactose. The results suggest that, unlike the enzyme galactose oxidase, due to the precipitation of Cu₂O, this reaction is not catalytic as would have been expected. The structures of 1 and 2 are monomeric, while 3 consists of a dimeric cation and a perchlorate anion [which is disordered over two orientations, with occupancies of 0.64 (4) and 0.36 (4)]. In all three structures, the central Cu atom is five‐coordinated in a distorted square‐pyramidal arrangment (τ parameter of 0.0932 for 1 , 0.0888 for 2 , and 0.142 and 0.248 for the two Cu centers in 3 ). In each species, the environment about the Cu atom is such that the vacant sixth position is open, with very little steric crowding.     

Salt forms of sulfadiazine with alkali metal and organic cations

The structures of four salt forms of sulfadiazine (SDH) with alkali metal cations are presented. Three contain the deprotonated SD anion (C₁₀H₉N₄O₂S). These are the discrete complex diaqua{4‐[(pyrimidin‐2‐ylazanidyl‐κN¹)sulfonyl‐κO]aniline}lithium(I), [Li(SD)(H₂O)₂], (I), and the coordination polymers poly[{μ₃‐4‐[(pyrimidin‐2‐ylazanidyl)sulfonyl]aniline}sodium(I)], [Na(SD)]_n, (II), and poly[diaqua{μ₃‐4‐[(pyrimidin‐2‐ylazanidyl)sulfonyl]aniline}potassium(I)], [K(SD)(H₂O)₂]_n, (III). Na complex (II) is a three‐dimensional coordination polymer, whilst K complex (III) has two crystallographically independent [K(SD)(H₂O)₂] units per asymmetric unit (Z′ = 2) and gives a two‐dimensional coordination polymer whose layers propagate parallel to the crystallographic ab plane. The different bonding modes of the SD anion in these three complexes is discussed. Structure (IV) contains protonated SDH₂ cations {4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium, C₁₀H₁₁N₄O₂S} and the Orange G dianion [OG, 7‐oxo‐8‐(phenylhydrazinylidene)naphthalene‐1,3‐disulfonate, C₁₆H₁₀N₂O₇S₂], namely, 4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium tetraaqua[7‐oxo‐8‐(phenylhydrazinylidene)naphthalene‐1,3‐disulfonato]sodium(I) sesquihydrate, (SDH₂)[Na(OG)(H₂O)₄]·1.5H₂O. The [Na(OG)(H₂O)₄]₂ dimers have antiparallel naphthyl ring structures joined through two Na centres that bond to the hydrazone anions through the O atoms of the ketone and sulfonate substituents. The structures of the salts formed on reaction of SDH with 2‐aminopyridine and ethanolamine are also presented as 2‐aminopyridinium 4‐[(pyrimidin‐2‐ylazanidyl)sulfonyl]aniline, [C₅H₇N₂][SD], (V), and ethanolaminium 4‐[(pyrimidin‐2‐ylazanidyl)sulfonyl]aniline monohydrate, [HOCH₂CH₂NH₃][SD]·H₂O, (VI), respectively. Structure (V) features a heterodimeric R₂²(8) hydrogen‐bond motif between the cation and the anion, whilst structure (VI) has a tetrameric core of two cations linked by a central R₂²(10) hydrogen‐bonded motif which supports two anions linked to this core by R₃³(8) motifs.     

Five solvates of a multicomponent pharmaceutical salt formed by berberine and diclofenac

A multicomponent pharmaceutical salt formed by the isoquinoline alkaloid berberine (5,6‐dihydro‐9,10‐dimethoxybenzo[g]‐1,3‐benzodioxolo[5,6‐a]quinolizinium, BBR) and the nonsteroidal anti‐inflammatory drug diclofenac {2‐[2‐(2,6‐dichloroanilino)phenyl]acetic acid, DIC} was discovered. Five solvates of the pharmaceutical salt form were obtained by solid‐form screening. These five multicomponent solvates are the dihydrate (BBR–DIC·2H₂O or C₂₀H₁₈NO₄⁺·C₁₄H₁₀Cl₂NO₂^?·2H₂O), the dichloromethane hemisolvate dihydrate (BBR–DIC·0.5CH₂Cl₂·2H₂O or C₂₀H₁₈NO₄⁺·C₁₄H₁₀Cl₂NO₂^?·0.5CH₂Cl₂·2H₂O), the ethanol monosolvate (BBR–DIC·C₂H₅OH or C₂₀H₁₈NO₄⁺·C₁₄H₁₀Cl₂NO₂^?·C₂H₅OH), the methanol monosolvate (BBR–DIC·CH₃OH or C₂₀H₁₈NO₄⁺·C₁₄H₁₀Cl₂NO₂^?·CH₃OH) and the methanol disolvate (BBR–DIC·2CH₃OH or C₂₀H₁₈NO₄⁺·C₁₄H₁₀Cl₂NO₂^?·2CH₃OH), and their crystal structures were determined. All five solvates of BBR–DIC (1:1 molar ratio) were crystallized from different organic solvents. Solvent molecules in a pharmaceutical salt are essential components for the formation of crystalline structures and stabilization of the crystal lattices. These solvates have strong intermolecular O…H hydrogen bonds between the DIC anions and solvent molecules. The intermolecular hydrogen‐bond interactions were visualized by two‐dimensional fingerprint plots. All the multicomponent solvates contained intramolecular N—H…O hydrogen bonds. Various π–π interactions dominate the packing structures of the solvates.     

The crystal and molecular structure of sodium 4‐(2,4,6‐triisopropylbenzoyl)benzoate in terms of the photochemical behaviour of the anion

Contrary to the known 4‐(2,4,6‐triisopropylbenzoyl)benzoate salts, di‐μ‐aqua‐bis[tetraaquasodium(I)] bis[4‐(2,4,6‐triisopropylbenzoyl)benzoate] dihydrate, [Na₂(H₂O)₁₀](C₂₃H₂₇O₃)₂·2H₂O, (1), does not undergo a photochemical Norrish–Yang reaction in the crystalline state. In order to explain this photochemical inactivity, the intermolecular interactions were analyzed by means of the Hirshfeld surface and intramolecular geometrical parameters describing the possibility of a Norrish–Yang reaction were calculated. The reasons for the behaviour of the title salt are similar crystalline environments for both the o‐isopropyl groups in the anion, resulting in similar geometrical parameters and orientations, and that these interaction distances differ significantly from those found in salts where the photochemical reaction occurs.     

Salt forms of the pharmaceutical amide dihydrocarbamazepine

Carbamazepine (CBZ) is well known as a model active pharmaceutical ingredient used in the study of polymorphism and the generation and comparison of cocrystal forms. The pharmaceutical amide dihydrocarbamazepine (DCBZ) is a less well known material and is largely of interest here as a structural congener of CBZ. Reaction of DCBZ with strong acids results in protonation of the amide functionality at the O atom and gives the salt forms dihydrocarbamazepine hydrochloride {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium chloride, C₁₅H₁₅N₂O⁺·Cl⁻}, dihydrocarbamazepine hydrochloride monohydrate {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium chloride monohydrate, C₁₅H₁₅N₂O⁺·Cl⁻·H₂O} and dihydrocarbamazepine hydrobromide monohydrate {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium bromide monohydrate, C₁₅H₁₅N₂O⁺·Br⁻·H₂O}. The anhydrous hydrochloride has a structure with two crystallographically independent ion pairs (Z′ = 2), wherein both cations adopt syn conformations, whilst the two hydrated species are mutually isostructural and have cations with anti conformations. Compared to neutral dihydrocarbamazepine structures, protonation of the amide group is shown to cause changes to both the molecular (C=O bond lengthening and C—N bond shortening) and the supramolecular structures. The amide‐to‐amide and dimeric hydrogen‐bonding motifs seen for neutral polymorphs and cocrystalline species are replaced here by one‐dimensional polymeric constructs with no direct amide‐to‐amide bonds. The structures are also compared with, and shown to be closely related to, those of the salt forms of the structurally similar pharmaceutical carbamazepine.